• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PICCOLO OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PICCOLO OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number 9-PDAP-05-02-L
Device Problems Migration or Expulsion of Device (1395); Improper or Incorrect Procedure or Method (2017); Migration (4003)
Patient Problem Embolism (1829)
Event Date 09/03/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
On (b)(6) 2020, a 5-4 amplatzer piccolo was selected for implant for a (b)(6) day old (b)(6) kg patient.The pda dimension was: 2.9mm minimal diameter, 4.4mm aortic ampulla, and 9.22m pda length.The 5-4 piccolo was deployed but not released as it was determined to not fit the pda appropriately.The device was removed and exchanged for a 5-2 piccolo and placed intraductal.Upon release, the 5-2 piccolo shifted toward the pulmonary artery.The device was snared in the inferior vena cava and migrated to the right pulmonary artery.The device was snared in the right pulmonary artery and removed.The physician reattempt to place the 5-2 piccolo in the pda.The placement looked good and it was decided to release the device.Ten minutes post release, the device embolized and was again snared and removed from the patient without incidence.An echo was performed and showed that was no valvular regurgitation or damage to the tricuspid valve or pulmonary valve.A large pda remained and the baby was referred to the surgery team for ligation.The baby remained very stable throughout the entire case.
 
Manufacturer Narrative
An event of migration was reported.A more comprehensive assessment could not be performed as a valve-in-valve procedure was performed and the device was not accessible for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.The cause of the reported incident could not be conclusively determined.A capa has been initiated to further investigate the reported event.Please note per the instruction for use, arten600042307 version a, a pda in a patient weighing fewer than 2kg and a pda with a minimum diameter of 2.9 mm and a length of 9.22mm, a 4/2mm piccolo is recommended per the sizing table.
 
Event Description
On (b)(6) 2020, a 5-4 amplatzer piccolo was selected for implant for a 31 day old 1.9kg patient.The patent ductus arteriosus (pda) dimension was: 2.9mm minimal diameter, 4.4mm aortic ampulla, and 9.22m pda length.The 5-4 piccolo was deployed but not released as it was determined to not fit the pda appropriately.The device was removed and exchanged for a 5-2 piccolo and placed intraductal.Upon release, the 5-2 piccolo shifted toward the pulmonary artery.The device was snared in the inferior vena cava and migrated to the right pulmonary artery.The device was snared in the right pulmonary artery and removed.The physician reattempt to place the same 5-2 piccolo in the pda again.The placement looked good and it was decided to release the device.Ten minutes post release, the device embolized and was again snared and removed from the patient without incidence.An echocardiography was performed and showed that that was no valvular regurgitation or damage to the tricuspid valve or pulmonary valve.A large pda remained and the baby was referred to the surgery team for ligation.The baby remained very stable throughout the entire case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PICCOLO OCCLUDER
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10596894
MDR Text Key213684268
Report Number2135147-2020-00417
Device Sequence Number1
Product Code MAE
UDI-Device Identifier05415067031037
UDI-Public05415067031037
Combination Product (y/n)N
PMA/PMN Number
P020024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/28/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-PDAP-05-02-L
Device Catalogue Number9-PDAP-05-02-L
Device Lot Number7162176
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age31 DA
Patient Weight2
-
-